Pediatric hidradenitis suppurativa faces diagnostic delays and stigma, while adalimumab shows superior drug survival compared with infliximab in children.
Tarannum Jaleel, MD, MS
Advertisement
Articles by Tarannum Jaleel, MD, MS
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Leucovorin Treatment Expansion for Autism Symptoms Under FDA Review
2
Teclistamab for R/R MM Effective and Safe When Administered in a Community Setting
3
Near Low–Income Medicare Beneficiaries Face More Affordability Problems Than Other Income Groups
4
Childhood Insurance Dynamics Predict Medicaid Cuts Will Widen Gaps
5
